Valion Bio (VBIO) Change in Cash (2021 - 2025)
Valion Bio (VBIO) posted quarterly Change in Cash of $9.2 million for Q4 2025, up 5017.11% year-over-year from $179691.2 in Q4 2024, and up 305.78% quarter-over-quarter from $2.3 million in Q3 2025.
Valion Bio (VBIO) Change in Cash (2021 - 2025) Analysis & Trends
Valion Bio's Change in Cash history runs 5 years deep, the most recent figure standing at $9.2 million for Q4 2025.
- In Q4 2025, Change in Cash rose 5017.11% year-over-year to $9.2 million; the TTM figure through Dec 2025 stood at $10.6 million (up 864.03% YoY), while the FY2025 annual figure was $10.6 million, up 864.03% from the prior year.
- Change in Cash for Q4 2025 stood at $9.2 million, up from $2.3 million in the prior quarter.
- The five-year high for Change in Cash was $12.1 million in Q4 2021, with the low at -$2.8 million in Q4 2022.
- The 5-year median for Change in Cash is -$609500.0 (2021), against an average of $580050.0.
- The sharpest annual moves came in 2022 and 2025: Change in Cash plunged 389.64% in 2022, then soared 5017.11% in 2025.
- Valion Bio's Change in Cash stood at $12.1 million in 2021, then slumped by 123.18% to -$2.8 million in 2022, then surged by 36.89% to -$1.8 million in 2023, then soared by 89.46% to -$187000.0 in 2024, then jumped by 5017.11% to $9.2 million in 2025.
- Business Quant data shows VBIO's Change in Cash at $9.2 million in Q4 2025, $2.3 million in Q3 2025, and $515000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.94 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -37.42 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 225.59 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -2.83 Bn |
| 10 | Valion Bio | 420,133.64 | -1.78 Mn | -45,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.20 Mn |
| Sep 30, 2025 | 2.27 Mn |
| Jun 30, 2025 | 515,000.00 |
| Mar 31, 2025 | -1.33 Mn |
| Dec 31, 2024 | -187,000.00 |
| Sep 30, 2024 | -1.50 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | -1.77 Mn |
| Sep 30, 2023 | 2.51 Mn |
| Jun 30, 2023 | -2.51 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | -2.81 Mn |
| Sep 30, 2022 | -2.72 Mn |
| Jun 30, 2022 | -1.75 Mn |
| Mar 31, 2022 | -2.17 Mn |
| Dec 31, 2021 | 12.13 Mn |
| Sep 30, 2021 | -775,000.00 |
| Jun 30, 2021 | 1.02 Mn |
| Mar 31, 2021 | -444,000.00 |